These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35640462)

  • 1. Cost-Effectiveness Analysis of Strategies of COVID-19 Vaccination in Colombia: Comparison of High-Risk Prioritization and No Prioritization Strategies With the Absence of a Vaccination Plan.
    Morales-Zamora G; Espinosa O; Puertas E; Fernández JC; Hernández J; Zakzuk V; Cepeda M; Alvis-Gúzman N; Castañeda-Orjuela C; Paternina-Caicedo A
    Value Health Reg Issues; 2022 Sep; 31():101-110. PubMed ID: 35640462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    Pearson CAB; Bozzani F; Procter SR; Davies NG; Huda M; Jensen HT; Keogh-Brown M; Khalid M; Sweeney S; Torres-Rueda S; ; ; Eggo RM; Vassall A; Jit M
    PLoS Med; 2021 Oct; 18(10):e1003815. PubMed ID: 34606520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
    Kohli M; Maschio M; Becker D; Weinstein MC
    Vaccine; 2021 Feb; 39(7):1157-1164. PubMed ID: 33483216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a potential Zika vaccine candidate: a case study for Colombia.
    Shoukat A; Vilches T; Moghadas SM
    BMC Med; 2018 Jul; 16(1):100. PubMed ID: 29966516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness analysis of South Africa's COVID-19 vaccination programme.
    Edoka I; Silal S; Jamieson L; Meyer-Rath G
    Vaccine; 2024 Aug; 42(20):125988. PubMed ID: 38824084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of Pneumococcal and Influenza Vaccines Administered to Children Less Than 5 Years of Age in a Low-Income District of Bogota, Colombia.
    Lara C; De Graeve D; Franco F
    Value Health Reg Issues; 2018 Dec; 17():21-31. PubMed ID: 29626706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Villanueva-Uy MET; Lam HY; Aldaba JG; Uy TMZ; Valverde HA; Silva MWT; Mooney J; Clark A; Pecenka C
    Vaccine; 2021 Nov; 39(48):7091-7100. PubMed ID: 34753614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prioritization of the Target Population for Coronavirus Disease 2019 (COVID-19) Vaccination Program in Thailand.
    Suphanchaimat R; Tuangratananon T; Rajatanavin N; Phaiyarom M; Jaruwanno W; Uansri S
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Vaccines for COVID-19 According to Sex, Comorbidity and Socioeconomic Status: A Population Study.
    Mar J; Ibarrondo O; Estadilla CDS; Stollenwerk N; Antoñanzas F; Blasco-Aguado R; Larrañaga I; Bidaurrazaga J; Aguiar M
    Pharmacoeconomics; 2024 Feb; 42(2):219-229. PubMed ID: 37910377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of Mucosal Leishmaniasis diagnosis with PCR-based vs parasitological tests in Colombia.
    Castillo-Rodríguez L; Ovalle-Bracho C; Díaz-Jiménez D; Sánchez-Vanegas G; Muvdi-Arenas S; Castañeda-Orjuela C
    PLoS One; 2019; 14(11):e0224351. PubMed ID: 31682606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing an influenza vaccination programme for adults aged ≥65 years in Poland: a cost-effectiveness analysis.
    Brydak L; Roiz J; Faivre P; Reygrobellet C
    Clin Drug Investig; 2012 Feb; 32(2):73-85. PubMed ID: 22201294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.
    Patel HD; Roberts ET; Constenla DO
    Vaccine; 2013 Dec; 31(51):6072-8. PubMed ID: 24176497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.
    Wang Y; Luangasanatip N; Pan-Ngum W; Isaranuwatchai W; Prawjaeng J; Saralamba S; Painter C; Briones JR; Teerawattananon Y
    Eur J Health Econ; 2023 Jul; 24(5):735-748. PubMed ID: 35951243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation using dynamic transition modeling of ebola virus vaccination in lower-and-middle-income countries.
    Obeng-Kusi M; Habila MA; Roe DJ; Erstad B; Abraham I
    J Med Econ; 2021 Nov; 24(sup1):1-13. PubMed ID: 34866541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated number of deaths directly avoided because of COVID-19 vaccination among older adults in Colombia in 2021: an ecological, longitudinal observational study.
    Rojas-Botero ML; Fernández-Niño JA; Arregocés-Castillo L; Ruiz-Gómez F
    F1000Res; 2022; 11():198. PubMed ID: 35811799
    [No Abstract]   [Full Text] [Related]  

  • 16. How severe would prioritization-induced bottlenecks need to be offset the benefits from prioritizing COVID-19 vaccination to those most at risk in New York City?
    Kim HY; Bershteyn A; McGillen JB; Braithwaite RS
    BMC Public Health; 2023 Jan; 23(1):174. PubMed ID: 36698103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological impact and cost-effectiveness analysis of COVID-19 vaccination in Kenya.
    Orangi S; Ojal J; Brand SP; Orlendo C; Kairu A; Aziza R; Ogero M; Agweyu A; Warimwe GM; Uyoga S; Otieno E; Ochola-Oyier LI; Agoti CN; Kasera K; Amoth P; Mwangangi M; Aman R; Ng'ang'a W; Adetifa IM; Scott JAG; Bejon P; Keeling MJ; Flasche S; Nokes DJ; Barasa E
    BMJ Glob Health; 2022 Aug; 7(8):. PubMed ID: 35914832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of pneumococcal conjugate vaccines of 7, 10, and 13 valences in Colombian children.
    Castañeda-Orjuela C; Alvis-Guzmán N; Velandia-González M; De la Hoz-Restrepo F
    Vaccine; 2012 Mar; 30(11):1936-43. PubMed ID: 22266291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia.
    Lee JS; Lourenço J; Gupta S; Farlow A
    Vaccine; 2018 Apr; 36(17):2346-2355. PubMed ID: 29573874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of the bivalent and quadrivalent human papillomavirus vaccines from a societal perspective in Colombia.
    Aponte-González J; Fajardo-Bernal L; Diaz J; Eslava-Schmalbach J; Gamboa O; Hay JW
    PLoS One; 2013; 8(11):e80639. PubMed ID: 24260441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.